Requirement of RORα for maintenance and antitumor immunity of liver-resident natural killer cells/ILC1s

Hepatology. 2022 May;75(5):1181-1193. doi: 10.1002/hep.32147. Epub 2021 Dec 6.

Abstract

Backgroud and aims: Liver type 1 innate lymphoid cells (ILC1s), also known as liver-resident natural killer (LrNK) cells, comprise a high proportion of total hepatic ILCs. However, factors regulating their maintenance and function remain unclear.

Approach and results: In this study, we found high expression of retinoid-related orphan nuclear receptor alpha (RORα) in LrNK cells/ILC1s. Mice with conditional ablation of retinoid-related orphan nuclear receptor alpha (Rorα) in LrNK cells/ILC1s and conventional natural killer (cNK) cells had decreased LrNK cells/ILC1s but normal numbers of cNK cells. RORα-deficient LrNK cells/ILC1s displayed increased apoptosis and significantly altered transcriptional profile. Using a murine model of colorectal cancer liver metastasis, we found that RORα conditional deficiency resulted in more aggressive liver tumor progression and impaired effector molecule expression in LrNK cells/ILC1s. Consequently, treatment with the RORα agonist efficiently limited liver metastases and promoted effector molecule expression of LrNK cells/ILC1s.

Conclusions: This study reveals a role of RORα in LrNK cell/ILC1 maintenance and function, providing insights into the harnessing of LrNK cell/ILC1 activity in the treatment of liver cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Immunity, Innate*
  • Killer Cells, Natural / metabolism
  • Liver Neoplasms* / metabolism
  • Mice
  • Orphan Nuclear Receptors / metabolism
  • Retinoids / metabolism

Substances

  • Orphan Nuclear Receptors
  • Retinoids